Evidence used
- No CISA KEV confirmation is currently recorded.
- Exploitation requires an existing local or physical foothold with privileges.
- EPSS is 0.09% for the current model date.
BlackTreeCVE IntelligenceUnknown · Intel(R) Processors
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Alpine, Debian, ubuntu findings are scoped to the named distribution, release and source package. An absent finding does not mean a package is unaffected.
A published vendor fix does not prove that a matching update is enabled and installable on a particular asset. Confirm the local package candidate before scheduling remediation.
| Distribution release | Source package | Vendor state | Fixed version | Evidence |
|---|---|---|---|---|
| Alpine v3.23v3.23 · main | intel-ucode | Vendor fix publishedAlpine records a security fix at this version. An absent entry does not mean the package is unaffected. | 20260812-r0 | Alpine Security Database ↗Source updated 3 Oct 2026 |
| Alpine v3.22v3.22 · main | intel-ucode | Vendor fix publishedAlpine records a security fix at this version. An absent entry does not mean the package is unaffected. | 20260812-r0 | Alpine Security Database ↗Source updated 3 Oct 2026 |
| Alpine v3.21v3.21 · main | intel-ucode | Vendor fix publishedAlpine records a security fix at this version. An absent entry does not mean the package is unaffected. | 20260812-r0 | Alpine Security Database ↗Source updated 3 Oct 2026 |
| Debian trixietrixie · source | intel-microcode | Affected, no fix publishedDebian currently tracks this release as open. | Not published in this feed | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian bookwormbookworm · source | intel-microcode | Affected, no fix publishedDebian currently tracks this release as open. | Not published in this feed | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian forkyforky · source | intel-microcode | Affected, no fix publishedDebian currently tracks this release as open. | Not published in this feed | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian sidsid · source | intel-microcode | Affected, no fix publishedDebian currently tracks this release as open. | Not published in this feed | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Ubuntu 24.04 LTSnoble · standard archive | intel-microcode | Under evaluationCanonical reports that the package might be affected and still needs evaluation or fixing. | Not published in this feed | Canonical Ubuntu Security ↗Source updated 5 Oct 2026 |
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedImproper access control for some Intel(R) Processors within Ring 3: User Applications may allow an escalation of privilege. Simple hardware adversary with an authenticated user combined with a high complexity attack may enable escalation of privilege. This result may potentially occur via local access when attack requirements are present with special internal knowledge and requires no user interaction. The potential vulnerability may impact the confidentiality (high), integrity (high) and availability (none) of the vulnerable system, resulting in subsequent system confidentiality (none), integrity (none) and availability (none) impacts.
Improper access control for some Intel(R) Processors within Ring 3: User Applications may allow an escalation of privilege. Simple hardware adversary with an authenticated user combined with a high complexity attack may enable escalation of privilege. This result may potentially occur via local access when attack requirements are present with special internal knowledge and requires no user interaction. The potential vulnerability may impact the confidentiality (high), integrity (high) and availability (none) of the vulnerable system, resulting in subsequent system confidentiality (none), integrity (none) and availability (none) impacts.
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
An attacker operating through local access may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Improper access control for some Intel(R) Processors within Ring 3: User Applications may allow an escalation of privilege. Simple hardware adversary with an authenticated user combined with a high complexity attack may enable escalation of privilege. This result may potentially occur via local access when attack requirements are present with special internal knowledge and requires no user interaction. The potential vulnerability may impact the confidentiality (high), integrity (high) and availability (none) of the vulnerable system, resulting in subsequent system confidentiality (none), integrity (none) and availability (none) impacts.
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
An attacker operating through local access may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-284: Improper Access Control. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:NCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 11 Aug 2026 · Last source change 12 Aug 2026, 15:50 UTC · CWE-284 · Improper Access Control
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.